Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
0.5848
+0.0060 (1.04%)
Jun 20, 2025, 4:00 PM - Market closed
Verrica Pharmaceuticals Employees
Verrica Pharmaceuticals had 71 employees as of December 31, 2024. The number of employees decreased by 29 or -29.00% compared to the previous year.
Employees
71
Change (1Y)
-29
Growth (1Y)
-29.00%
Revenue / Employee
$101,113
Profits / Employee
-$929,437
Market Cap
54.09M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
VRCA News
- 24 days ago - Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York - GlobeNewsWire
- 5 weeks ago - Verrica Pharmaceuticals, Inc. (VRCA) Q1 2025 Corporate Update Conference Call - Seeking Alpha
- 5 weeks ago - Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025 - GlobeNewsWire
- 7 weeks ago - Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York - GlobeNewsWire
- 2 months ago - Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors - GlobeNewsWire
- 2 months ago - Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 3 months ago - Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D. - GlobeNewsWire